1. Home
  2. RQI vs EVO Comparison

RQI vs EVO Comparison

Compare RQI & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RQI
    SELLHOLDBUYas of 2 days ago
  • EVO
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • RQI 2002
  • EVO 1993
  • Country
  • RQI United States
  • EVO Germany
  • Employees
  • RQI N/A
  • EVO N/A
  • Industry
  • RQI Trusts Except Educational Religious and Charitable
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • RQI Finance
  • EVO Health Care
  • Exchange
  • RQI Nasdaq
  • EVO Nasdaq
  • Market Cap
  • RQI 1.7B
  • EVO 1.6B
  • IPO Year
  • RQI N/A
  • EVO 2021
  • Fundamental
  • Price
  • RQI $12.48
  • EVO $3.31
  • Analyst Decision
  • RQI
  • EVO Buy
  • Analyst Count
  • RQI 0
  • EVO 2
  • Target Price
  • RQI N/A
  • EVO $5.90
  • AVG Volume (30 Days)
  • RQI 432.6K
  • EVO 115.7K
  • Earning Date
  • RQI 01-01-0001
  • EVO 05-21-2025
  • Dividend Yield
  • RQI 8.20%
  • EVO N/A
  • EPS Growth
  • RQI N/A
  • EVO N/A
  • EPS
  • RQI N/A
  • EVO N/A
  • Revenue
  • RQI N/A
  • EVO $866,665,179.00
  • Revenue This Year
  • RQI N/A
  • EVO $3.70
  • Revenue Next Year
  • RQI N/A
  • EVO $10.32
  • P/E Ratio
  • RQI N/A
  • EVO N/A
  • Revenue Growth
  • RQI N/A
  • EVO N/A
  • 52 Week Low
  • RQI $9.17
  • EVO $2.85
  • 52 Week High
  • RQI $12.64
  • EVO $7.98
  • Technical
  • Relative Strength Index (RSI)
  • RQI 44.31
  • EVO 30.48
  • Support Level
  • RQI $12.29
  • EVO $3.38
  • Resistance Level
  • RQI $12.64
  • EVO $3.63
  • Average True Range (ATR)
  • RQI 0.23
  • EVO 0.10
  • MACD
  • RQI -0.02
  • EVO -0.00
  • Stochastic Oscillator
  • RQI 50.00
  • EVO 14.94

Stock Price Comparison Chart: RQI vs EVO

RQI
EVO
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250246810121416182022242628RQI VS EVO

About RQI Cohen & Steers Quality Income Realty Fund Inc

COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the Fund is high current income through investment in real estate securities. Its secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use